Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Deutsche Bank Downgrades Amedisys to Hold, Maintains Price Target to $101

Author: Benzinga Newsdesk | July 31, 2024 07:48am

Deutsche Bank analyst Justin Bowers downgrades Amedisys (NASDAQ:AMED) from Buy to Hold and maintains the price target from $101 to $101.

Posted In: AMED